Myeloid Malignancy Workshop

Friday, March 21, 2025, 7:00 AM - 6:00 PM, Leon & Norma Hess Center for Science and Medicine, Davis Auditorium, 1470 Madison Avenue, New York, NY


This workshop will include speakers with international recognition for excellence in science and clinical care of myeloid malignancies. Given the relative rarity of each disease, rapid pace of scientific discovery over the last several years, recent approval of novel agents, and the multitude of investigational agents in late-stage clinical development it is imperative to provide cutting edge updates in a focused manner. The target audience for this CME-accredited event will include clinical and laboratory-based physicians, trainees, laboratory investigators, pharmacists, nurses, nurse practitioners, physician assistants, and patients. The event would take place in a lecture hall on the campus of Mount Sinai. The talks will be 30 minutes in duration and followed by 10-minute question and answer sessions. The event will be moderated by John Mascarenhas, Marina Kremyanskaya and Ruben Mesa and the audience will be encouraged to participate in Q&A sessions. Additionally, there will be audience response system (ARS) questions before and after to gauge impact on learning.

1. Understand modern laboratory tools for exploring myeloid malignancy pathway for therapeutic targeting
2. Recognize the appropriate evidence-based therapies for patients with myeloid leukemia
3. Understand complex cellular mechanisms driving thrombosis in myeloproliferative neoplasms
4. Identify patient specific approaches and therapeutic options for patients with myelodysplastic syndromes
5. Discuss the emerging results of laboratory and clinical studies providing insights into biology and potential interventions in CHIP/CCUS
6. Identify treatment goals for systemic mastocytosis that incorporate next generation kit inhibitors.

Physicians	$100
Lab Based	$75
Residents/Fellows/Trainee	Complimentary
Nurse/NP/PA/Pharmacy	Complimentary
Industry	$150

 

**Complimentary registration for residents, fellows, nurses, nurse practitioners, physician assistants, and pharmacists email [email protected] with a copy of your hospital ID to receive a Complimentary Online Registration Code.

Cancellation Policy: All refund and cancellation requests must be emailed to the CME office at [email protected] by February 21, 2025. Cancellations after this date are not eligible for a refund. An administrative fee of $50 will be deducted from your refund. No refunds will be issued for registration fees that are equal to or less than $50.

Directions and/or Parking: http://icahn.mssm.edu/about/visiting

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (6.00 hours), Non-Physician Attendance (6.00 hours)

For the convenience of attendees, an exclusive group rate is available at the Park Lane Hotel, 36 Central Park South, New York, NY 10019. This luxurious hotel offers stunning park views, elegant accommodations, and top-notch amenities. For questions or to receive the booking link, please email [email protected].

Mitigation of Relevant Financial Relationships

It is the policy of Icahn School of Medicine at Mount Sinai (ISMMS) to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-accredited educational activities. All faculty participating in the planning or implementation of an activity accredited by ISMMS are expected to disclose all of their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Friday, March 21, 2025